VICO Therapeutics B.V.
www.vicotx.comVico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting spinocerebellar ataxia types 3 and 1 and Huntington’s disease. Our VICOMER platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com
Read more
Vico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting spinocerebellar ataxia types 3 and 1 and Huntington’s disease. Our VICOMER platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com
Read more
Country
City (Headquarters)
Leiden
Industry
Employees
11-50
Founded
2019
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Scientific Officer ( Chief Security Officer ) / Site Head
Email ****** @****.comPhone (***) ****-****Director Cmc
Email ****** @****.comPhone (***) ****-****Non - Executive Director
Email ****** @****.comPhone (***) ****-****Director Operations
Email ****** @****.comPhone (***) ****-****
Technologies
(18)
